```html

Wegener’s Cellulitis – A Comprehensive Medical Guide

Overview

Wegener’s cellulitis is not a formally recognized medical diagnosis. The term appears to be a conflation of two separate conditions:

• Granulomatosis with polyangiitis (GPA) – formerly called Wegener’s granulomatosis – an autoimmune vasculitis that affects small‑ and medium‑sized blood vessels, most commonly the respiratory tract and kidneys.
• Cellulitis – a bacterial infection of the skin and subcutaneous tissue, usually caused by Staphylococcus aureus or Streptococcus pyogenes.

Because both conditions can involve skin lesions and systemic symptoms, some patients (and even a few outdated sources) mistakenly refer to a “Wegener’s cellulitis.” This guide covers the two distinct diseases, explains how they differ, and provides the practical information a patient might be looking for when they encounter the combined term.

Who it affects

• GPA: Primarily adults aged 40‑65, slightly more common in men. Incidence in the United States is about 12–14 new cases per million people per year (NIH).
• Cellulitis: Can affect anyone, but risk increases with age, diabetes, obesity, peripheral vascular disease, and skin breaks. In the U.S. there are roughly 2–3 million emergency‑department visits for cellulitis each year (CDC).

Symptoms

Below is a combined symptom list. When reading, note which symptoms belong to GPA, which belong to cellulitis, and which could arise from both.

Granulomatosis with Polyangiitis (GPA)

• Upper‑respiratory signs – chronic sinusitis, nasal crusting, nosebleeds, ear pain, or hearing loss.
• Lower‑respiratory signs – cough, shortness of breath, chest pain, hemoptysis (coughing blood).
• Renal involvement – blood in urine, proteinuria, swelling of ankles, reduced kidney function.
• Skin lesions – palpable purpura, ulcerated nodules, or vesiculobullous eruptions that may mimic cellulitis.
• Generalized symptoms – fever, fatigue, weight loss, night sweats, arthralgia (joint pain).

Cellulitis

• Red, warm, swollen, and painful area of skin, usually on the lower legs or arms.
• Rapid expansion of the redness (often spreading 1–2 cm per hour).
• Fever, chills, and malaise.
• Skin may develop blisters or bullae if infection is severe.
• Possible lymphangitic streaking (red lines) indicating spread along lymphatic channels.

Overlap (Why confusion occurs)

• Both can present with painful, erythematous skin lesions.
• Systemic fever and malaise are common to both.
• In GPA, skin lesions can become secondarily infected, leading to true cellulitis superimposed on vasculitic rash.

Causes and Risk Factors

Granulomatosis with Polyangiitis (GPA)

• Autoimmune mechanism – The body produces anti‑neutrophil cytoplasmic antibodies (ANCA), most often the proteinase‑3 (PR3‑ANCA) type, which trigger inflammation of blood vessels.
• Genetic predisposition – Certain HLA‑DQ alleles are associated with higher risk.
• Environmental triggers – Infections (especially respiratory), silica dust exposure, and certain drugs have been implicated, though causality is not proven.
• Age & sex – Peak incidence in middle‑aged adults; slight male predominance.

Cellulitis

• Skin break – Cuts, scratches, insect bites, surgical wounds, or chronic ulcerations.
• Comorbid conditions – Diabetes mellitus, peripheral arterial disease, lymphedema, chronic venous insufficiency, obesity.
• Immune compromise – Steroid use, chemotherapy, HIV/AIDS.
• Previous cellulitis – Prior infection damages skin integrity, raising recurrence risk.

Diagnosis

Granulomatosis with Polyangiitis (GPA)

1. Clinical evaluation – Detailed history of ENT, pulmonary, renal and skin symptoms.
2. Laboratory tests
   • ANCA serology (PR3‑ANCA positive in ~80% of cases).
   • Complete blood count (CBC), erythrocyte sedimentation rate (ESR), C‑reactive protein (CRP) – usually elevated.
   • Urinalysis for hematuria or proteinuria.
3. Imaging
   • Chest X‑ray or CT scan – shows nodules, cavitary lesions, or infiltrates.
   • Sinus CT – evaluates sinusitis, bony destruction.
4. Biopsy – Tissue from affected organ (skin, nasal mucosa, lung) showing necrotizing granulomatous inflammation and vasculitis is the gold‑standard.

Cellulitis

1. Physical examination – Classic signs of redness, warmth, swelling, and tenderness.
2. Laboratory studies
   • CBC – often shows leukocytosis with left shift.
   • CRP/ESR – elevated but non‑specific.
   • Blood cultures – recommended if fever >38.5 °C, signs of systemic toxicity, or immunocompromise.
3. Imaging (when needed)
   • Ultrasound – helps differentiate cellulitis from abscess or deep‑vein thrombosis.
   • MRI – reserved for suspected necrotizing fasciitis or osteomyelitis.
4. Culture – Not routinely done for uncomplicated cellulitis, but wound culture may be taken if an ulcer or drainage is present.

Treatment Options

Granulomatosis with Polyangiitis (GPA)

Treatment aims to induce remission, then maintain it with lower‑dose agents.

• Induction therapy
  • High‑dose glucocorticoids (e.g., prednisone 1 mg/kg daily, then taper).
  • Immunosuppressive agents:
    • Rituximab (375 mg/m² weekly × 4) – preferred over cyclophosphamide in many patients (RAVE trial, NEJM 2013).
    • Cyclophosphamide (IV 15 mg/kg every 2–3 weeks or oral 2 mg/kg/day) – used when rituximab is contraindicated.
• Maintenance therapy
  • Rituximab (500 mg every 6 months) or azathioprine, methotrexate, or mycophenolate mofetil for 18–24 months.
  • Low‑dose prednisone (≤10 mg/day) while tapering.
• Adjunctive care
  • Prophylactic trimethoprim‑sulfamethoxazole to prevent Pneumocystis jirovecii pneumonia (PCP) and recurrent sinus infections.
  • Vaccinations (influenza, pneumococcal, COVID‑19) once disease is controlled.

Cellulitis

• Antibiotic therapy – Empiric coverage for streptococci and staphylococci:
  • Mild‑moderate: oral dicloxacillin, cephalexin, or clindamycin (if MRSA risk is low).
  • MRSA risk or severe infection: doxycycline, TMP‑SMX, or linezolid; consider adding a β‑lactam for streptococcal coverage.
  • Severe or systemic infection: IV vancomycin plus cefazolin or ceftriaxone, then step‑down to oral when stable.
• Supportive measures
  • Elevation of the affected limb to reduce edema.
  • Analgesia (acetaminophen or NSAIDs if no contraindication).
  • Warm compresses may ease discomfort.
• Adjuncts for specific scenarios
  • Abscess formation – incision & drainage plus antibiotics.
  • Recurrent cellulitis – prophylactic low‑dose antibiotics (e.g., penicillin V 250 mg BID) for 6–12 months, or treat underlying lymphedema.

Living with Wegener’s Cellulitis

Because the term usually reflects a patient who has both GPA‑related skin involvement and episodes of bacterial cellulitis, management must address both chronic autoimmune disease and infection risk.

Daily Management Tips

• Skin care – Keep skin clean, moisturized, and free of cracks. Inspect feet and legs daily, especially if you have diabetes or peripheral neuropathy.
• Wound hygiene – Promptly clean any cuts or abrasions, use antiseptic (iodine or chlorhexidine), and cover with a sterile dressing.
• Medication adherence – Take immunosuppressants exactly as prescribed; set reminders or use a pill organizer.
• Monitor for flare‑ups – Keep a symptom diary (nasal discharge, cough, urine changes, new skin lesions). Early reporting can prevent organ damage.
• Vaccinations – Annual flu shot, COVID‑19 boosters, and pneumococcal vaccine are essential.
• Healthy lifestyle – Balanced diet rich in fruits/vegetables, regular moderate exercise, and weight control lower cellulitis recurrence.
• Foot protection – Wear well‑fitted shoes, avoid walking barefoot in public areas, and use protective padding if you have neuropathy.

Psychosocial Support

Living with a chronic vasculitis and frequent infections can be stressful. Consider:

• Support groups (local or online) for GPA.
• Counseling or cognitive‑behavioral therapy for anxiety/depression.
• Patient education resources from the American College of Rheumatology (ACR) and CDC.

Prevention

• For cellulitis
  • Control diabetes and peripheral vascular disease.
  • Treat chronic venous insufficiency with compression stockings.
  • Manage lymphedema with decongestive therapy.
  • Avoid tight clothing that can cause skin irritation.
• For GPA flares
  • Maintain consistent immunosuppressive regimen.
  • Avoid tobacco and excessive alcohol, which can exacerbate vasculitis.
  • Promptly treat respiratory infections; consider prophylactic antibiotics if you’re on high‑dose steroids.

Complications

• GPA complications
  • Permanent kidney damage leading to chronic kidney disease or end‑stage renal disease (ESRD).
  • Permanent lung scarring, pulmonary hypertension.
  • Nasopharyngeal stenosis or saddle‑nose deformity.
  • Increased risk of opportunistic infections due to immunosuppression.
• Cellulitis complications
  • Abscess formation.
  • Necrotizing fasciitis (a surgical emergency).
  • Septicemia or bacteremia.
  • Deep vein thrombosis from prolonged limb immobility.
• Combined impact
  • Immunosuppression for GPA raises the risk of severe cellulitis, which in turn can trigger systemic inflammation and potentially worsen vasculitis activity.

When to Seek Emergency Care

References

• Mayo Clinic. Granulomatosis with polyangiitis (Wegener’s). https://www.mayoclinic.org/diseases‑conditions/granulomatosis‑with‑polyangiitis
• CDC. Cellulitis: Clinical Information. https://www.cdc.gov/skin/infections/cellulitis.html
• National Institutes of Health. Granulomatosis with Polyangiitis (GPA) Clinical Trials. https://clinicaltrials.gov/ct2/results?cond=Granulomatosis+with+Polyangiitis
• Raveendran et al. “Rituximab versus cyclophosphamide for induction of remission in GPA.” New England Journal of Medicine. 2013;369:507‑516.
• World Health Organization. Guidelines for the Management of Skin and Soft‑Tissue Infections. 2022.
• Cleveland Clinic. Cellulitis: Symptoms, Causes, and Treatment. https://my.clevelandclinic.org/health/diseases/15297-cellulitis

```